TNF and melanoma: Analyzing blood from 21 patients on multiple vaccine trials who responded versus those that did not, researchers observed that melanoma patients who had a complete response were producing Th1-associated cytokines such as tumor necrosis factor (TNF) and interferon gamma (IFN-γ), unlike patients who had no response to the vaccine (6).